MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-24-0005627
Vovantis Laboratories Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹76.05 Cr
▲ 67% YoY
Net profit · FY 2025
₹3.82 Cr
Net margin 5%
EBITDA · FY 2025
₹12.12 Cr
EBITDA margin 15.9%
Authorised capital
₹31 Cr
Registered with MCA
Paid-up capital
₹28.5 Cr
Issued & subscribed
Open charges
₹24.73 Cr
Satisfied ₹18.78 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
138
Provident fund records
About Vovantis Laboratories Private Limited
Data last updated:
Vovantis Laboratories Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 October 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2008PTC055176. Its GSTIN is 24AACCV8491K1ZT (Gujarat).
The company has an authorised share capital of ₹31 Cr and a paid-up capital of ₹28.5 Cr. It is led by directors including Brijesh Khandelwal and Vinayak Kamalakar Nayak.
Its last annual general meeting (AGM) was held on 25 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Opp Ranoli Railway Station Nr Gacl Plant Ranoli, Vadodara, Gujarat, India – 391350.
As per the financials filed for FY 2025, the company reported a revenue of ₹76.05 Cr, a growth of 67% compared to the previous year. For the same year it recorded a net profit of ₹3.82 Cr (net margin 5%) and EBITDA of ₹12.12 Cr (EBITDA margin 15.9%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 19% over five years.
The company has about 138 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Vovantis Laboratories. As per MCA filings, the company has open charges of ₹24.73 Cr and satisfied charges of ₹18.78 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹13.59 Cr; the latest was in July 2019. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Vasa Pharma Chem Pvt Ltd with revenue of ₹77.38 Cr.
Vovantis Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0005627). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vovantis.com.
Company details
CIN U24230GJ2008PTC055176
Registration Number 055176
Incorporation Date 06 October 2008
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 July 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-24-0005627
Key People
Brijesh Khandelwal Director Vinayak Kamalakar Nayak Director Mohal Kartikeya Sarabhai Director Recognitions & Rankings of Vovantis Laboratories
Contact details
Vovantis Laboratories Private Limited's registered office is in Vadodara, Gujarat. Its website is vovantis.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOpp Ranoli Railway Station Nr Gacl Plant Ranoli, Vadodara, Gujarat, India – 391350
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vovantis Laboratories Private Limited, buy the company report.
Comprehensive company report
Vovantis Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Vovantis Laboratories operates one associated brand: Vovantis Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures novel effervescent drug delivery systems. | vovantis.com |
Business activity
The main business activity of Vovantis Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vovantis Laboratories Private Limited, buy the company report.
Financials of Vovantis Laboratories Private Limited
FY 2025 filings availableVovantis Laboratories Private Limited reported revenue of ₹76.05 Cr (up 67% YoY) for FY 2025.
Revenue · FY 2025
₹76.05 Cr ▲ 67%
Net profit · FY 2025
₹3.82 Cr margin 5%
EBITDA · FY 2025
₹12.12 Cr margin 15.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 67%
3 years · compounded
▲ 5%
5 years · compounded
▲ 19%
EBITDA CAGR growth
3 years · compounded
▲ 1%
5 years · compounded
▲ 35%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 67% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.12 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.82 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.9% | ||||
| Net Profit Margin | 5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vovantis Laboratories Private Limited, buy the company report.
Board of directors of Vovantis Laboratories Private Limited
Vovantis Laboratories has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brijesh Khandelwal Also directs: Ambalal Sarabhai Enterprises Limited | Director | 09 Oct 2024 | 2 Years 0 Months | Current |
| Vinayak Kamalakar Nayak | Director | 22 Aug 2013 | 13 Years 2 Months | Current |
| Mohal Kartikeya Sarabhai Also directs: Ambalal Sarabhai Enterprises Limited, Cosara Diagnostics Private Limited, Asence Pharma Private Limited and 5 more | Director | 06 Oct 2008 | 18 Years 0 Months | Current |
| Sultan Abbas Reshamwala | Director | 22 Aug 2013 | 13 Years 2 Months | Current |
Peer comparison
Vovantis Laboratories Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vasa Pharma Chem Pvt Ltd | ₹77.38 Cr (FY 2025) | -8.0% | Ahmedabad, Gujarat, India | |||
| Vapi Care Pharma Private Limited | ₹76.81 Cr (FY 2025) | -11.0% | Vapi, Valsad, Gujarat, India | |||
| Eskag Pharma Pvt Ltd | ₹76.72 Cr (FY 2024) | 0.0% | Kolkata, West Bengal, India | |||
| Mercury Laboratories Limited | ₹76.17 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Vovantis Laboratories Private Limitedthis company | ₹76.05 Cr (FY 2025) | ₹3.82 Cr | 5% | 67.0% | 138 | Vadodara, Gujarat, India |
| Higlance Laboratories Private Limited | ₹75.98 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| Vital Therapeutics and Formulations Private Limited | ₹75.96 Cr (FY 2024) | 2.0% | Hyderabad, Telangana, India | |||
| Bennet Pharmaceuticals Limited | ₹75.82 Cr (FY 2025) | 11.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Vovantis Laboratories Private Limited, buy the company report.
Auditor
Vovantis Laboratories Private Limited is audited by G. K. CHOKSHI & CO. for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G. K. CHOKSHI & CO. | FY 2021 | 101895W |
Shareholding
The shareholding of Vovantis Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vovantis Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹24.73 Cr
Satisfied charges
₹18.78 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Nov 2020 | 100394207 | Axis Bank Limited | ₹14.93 Cr | Open | |
| 27 Dec 2019 | 100316854 | Axis Bank Limited | ₹9.8 Cr | Open | |
| 21 Aug 2017 | 100121829 | Bank of India | ₹75 Lakh | Satisfied | |
| 03 Feb 2016 | 10622870 | Bank of India | ₹2 Cr | Satisfied | |
| 02 Mar 2015 | 10564979 | Bank of India | ₹1 Cr | Satisfied |
To see the full charge records of Vovantis Laboratories Private Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Vovantis Laboratories Private Limited has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹13.59 Cr; the latest was in July 2019.
Total deals
6
Funding rounds
3
Secondary share transfers
2
Rights issue
1
Disclosed funding
₹13.59 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2019 | Rights issue | ₹25.34 Cr | Investors: Nishta Life Sciences LLC, Dansar Technologies Llc, Asence Pharma Private Limited |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: Dansar Technologies Llc, Nishta Life Sciences LLC Seller: Ambalal Sarabhai Enterprises Limited , Alpha B Conseil SARL, Asence Pharma Private Limited |
| Dec 2012 | Funding round | ₹1.8 Cr | Investors: Alpha B Conseil SARL, Ambalal Sarabhai Enterprises Limited , Asence Pharma Private Limited |
| Jun 2011 | Funding round | ₹5.06 Cr | Investors: Ambalal Sarabhai Enterprises Limited , Alpha B Conseil SARL, Asence Pharma Private Limited |
| Sep 2009 | Secondary share transfer | Undisclosed | Buyer: Alpha B Conseil SARL Seller: Ambalal Sarabhai Enterprises Limited , 2 individuals |
To see the full deal history of Vovantis Laboratories Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Vovantis Laboratories Private Limited has 1 court case on record: 1 filed by Vovantis Laboratories. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Special civil application | Filed by the company against Union of India and 5 others | Disposed |
To see the full case history of Vovantis Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vovantis Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Vovantis Laboratories has 2 joint ventures. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Joint ventures
Employees & EPFO
Vovantis Laboratories Private Limited has a workforce of 138 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
138
Active EPFO establishments
1
Employee growth
-8.61%
GST
Vovantis Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCV8491K1ZT | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vovantis Laboratories Private Limited, buy the company report.
Recent activity
Vovantis Laboratories Private Limited has 10 board changes on record since 2008: 4 appointments and 6 cessations. The latest: Brijesh Khandelwal was appointed as Director on 09 Oct 2024.
Charges
A charge with Axis Bank Limited of Rs. 9.80 Cr registered on 27 Dec 2019 with Charge ID 100316854 was modified on 26 Aug 2025.
AGM
Vovantis Laboratories Private Limited last Annual general meeting of members was held on 25 Jul 2025 as per latest MCA records.
Filing
Vovantis Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Brijesh Khandelwal was appointed as Director.
Charges
A charge with Axis Bank Limited of Rs. 14.93 Cr registered on 24 Nov 2020 with Charge ID 100394207 was modified on 19 Sep 2024.
Ceased
Anilkumar Harilal Parekh ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 14.93 Cr with Charge ID 100394207 was registered on 24 Nov 2020.
Charges
A charge registered on 21 Aug 2017 via Charge ID 100121829 with Bank Of India was fully satisfied on 25 Sep 2020.
Charges
A charge registered on 03 Feb 2016 via Charge ID 10622870 with Bank Of India was fully satisfied on 25 Sep 2020.
Charges
A charge registered on 02 Mar 2015 via Charge ID 10564979 with Bank Of India was fully satisfied on 25 Sep 2020.
Charges
A charge registered on 18 May 2010 via Charge ID 10223330 with Bank Of India was fully satisfied on 25 Sep 2020.
Charges
A charge registered on 18 May 2010 via Charge ID 10223332 with Bank Of India was fully satisfied on 25 Sep 2020.
21 earlier events are in the company report.
Frequently asked questions
Vovantis Laboratories is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 October 2008 (18+ years old) and is registered under CIN U24230GJ2008PTC055176.
Vovantis Laboratories has 4 current directors:
- Brijesh Khandelwal - Director
- Vinayak Kamalakar Nayak - Director
- Mohal Kartikeya Sarabhai - Director
- Sultan Abbas Reshamwala - Director
The latest financial statements of Vovantis Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vovantis Laboratories is 24AACCV8491K1ZT, registered in Gujarat.
The CIN (Corporate Identification Number) of Vovantis Laboratories is U24230GJ2008PTC055176. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vovantis Laboratories has 1 court case on record: 1 filed by the company.
Vovantis Laboratories was incorporated on 06 October 2008, making it 18+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Vovantis Laboratories has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹13.59 Cr; the latest was in July 2019.
The peers of Vovantis Laboratories by revenue are Vasa Pharma Chem Pvt Ltd, Vapi Care Pharma Private Limited, Eskag Pharma Pvt Ltd, Mercury Laboratories Limited, Higlance Laboratories Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Brijesh Khandelwal was appointed as Director on 09 Oct 2024. Anilkumar Harilal Parekh ceased to be Director on 08 Aug 2024. Sultan Abbas Reshamwala ceased to be Additional Director on 30 Sep 2015. Vovantis Laboratories has 10 board changes on record in total.
Yes, Vovantis Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-24-0005627).